相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Cost-Effectiveness of 5-Aminosalicylic Acid Therapy for Maintenance of Remission in Ulcerative Colitis
Eugene F. Yen et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2008)
Activation-induced cytidine deaminase links between inflammation and the development of colitis-associated colorectal cancers
Yoko Endo et al.
GASTROENTEROLOGY (2008)
European evidence-based Consensus on the management of ulcerative colitis: Current management
S. P. L. Travis et al.
JOURNAL OF CROHNS & COLITIS (2008)
Review article: increasing the dose of oral mesalazine therapy for active ulcerative colitis does not improve remission rates
A. V. Safdi et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2007)
5-aminosalicylic acid therapy and the risk of colorectal cancer among patients with inflammatory bowel disease
Jonathan P. Terdiman et al.
INFLAMMATORY BOWEL DISEASES (2007)
Effect of once- or twice-daily MMX mesalamine (SPD476) for the induction of remission of mild to moderately active ulcerative colitis
Gary R. Lichtenstein et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2007)
Once-daily, high-concentration MMX mesalamine in active ulcerative colitis
Michael A. Kamm et al.
GASTROENTEROLOGY (2007)
Cost analysis and cost determinants in a European inflammatory bowel disease inception cohort with 10 years of follow-up evaluation
Selwyn Odes et al.
GASTROENTEROLOGY (2006)
PPAR gamma as a new therapeutic in inflammatory bowel diseases
L. Dubuquoy et al.
GUT (2006)
5-aminosalicylate use and colorectal cancer risk in inflammatory bowel disease: a large epidemiological study
TP van Staa et al.
GUT (2005)
Chemoprevention of colorectal neoplasia in ulcerative colitis: The effect of 6-mercaptopurine
S Matula et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2005)
Effect of 5-aminosalicylate use on colorectal cancer and dysplasia risk: A systematic review and metaanalysis of observational studies
FS Velayos et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2005)
A new oral delivery system for 5-ASA: Preliminary clinical findings for MMx
C Prantera et al.
INFLAMMATORY BOWEL DISEASES (2005)
Intestinal antiinflammatory effect of 5-aminosalicylic acid is dependent on peroxisome proliferator-activated receptor-γ
C Rousseaux et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2005)
Long-term oral plus topical mesalazine in frequently relapsing ulcerative colitis
G Frieri et al.
DIGESTIVE AND LIVER DISEASE (2005)
IKKβ links inflammation and tumorigenesis in a mouse model of colitis-associated cancer
FR Greten et al.
CELL (2004)
Gastrointestinal transit and 5-ASA release from a new mesalazine extended-release formulation
M Brunner et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2003)
Mucosal 5-aminosalicylic acid concentration inversely correlates with severity of colonic inflammation in patients with ulcerative colitis
G Frieri et al.
GUT (2000)
分享论文
